News
Vetigenics: Bridging biotechnology and veterinary care for a healthier future
February 21, 2025
Vetigenics is transforming the treatment of challenging diseases in pets with innovative technology that generates best-in-class antibody therapies.
Read More
Vetigenics secures $6 million seed financing, sees meaningful clinical progress
February 3, 2025
Pet biotech establishes board of directors, looks ahead to therapies for autoimmune disease, obesity and allergy.
Read More
Looking back, looking forward: Penn’s CAR-T program continues path of progress
August 28, 2024
In 2018, at the height of the chimeric antigen receptor T-cell therapy revolution and in the heart of its implementation,...
Read More
Could pharma’s blockbuster immunotherapies work in dogs?
July 9, 2024
Vetigenics believes it’s found a way to make pricey antibody-based technologies more accessible for animals. Read More
Read More
Vetigenics begins canine bladder cancer trial
May 23, 2024
Animal Health | Headline Analysis US start-up Vetigenics has commenced its pilot clinical trial for a canine anti-cPD1 monoclonal antibody....
Read More
First canine patient receives Vetigenics’ fully canine anti-CTLA4 monoclonal antibody for oral melanoma
November 7, 2023
Two fully funded pilot studies to treat cancer free for pet owners who bring their dogs to research sites. PHILADELPHIA,...
Read More
Vetigenics’ Canibody platform attracting more potential collaborators
June 30, 2023
US pet therapeutics start-up Vetigenics is seeing increased interest from potential collaborators in its Canibody. Adriann Sax, the co-founder and...
Read More
Enhancing Canine Wellness: The Promise of Immunotherapy for Dogs
June 9, 2023
Given that dogs are widely regarded as ‘man’s best friend’, it makes sense that we are constantly striving to find...
Read More
Vetigenics Announces Second Discovery Collaboration with a Major Animal Health Pharma
November 8, 2022
New partnership established to explore multiple novel therapeutic antibodies for treating challenging pet diseases. Read More
Read More
Vetigenics Announces Publication of Comprehensive Preclinical Data for Anti-Canine CTLA4 Monoclonal Antibody
January 5, 2022
Published study confirms validity of the first entirely canine phage display technology to generate unique canine immunotherapy for treating canine...
Read More